vimarsana.com

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

Related Keywords

Boston ,Massachusetts ,United States ,Feng Xuan ,Spear Bio ,Donald Ingber ,Yu Wang ,Emily Henderson ,Centers For Disease ,Harvard Office Of Technnology Development ,Digital Biology Inc ,Harvard Medical School ,Technology Access Framework ,Spear Bio Inc ,Ultivue Inc ,Wyss Institute ,Wyss Institute Molecular Robotics Initiative ,Deo Health ,Bio Acting Head Of Application Development ,Harvard Johna Paulson School Of Engineering ,Torus Biosystems Inc ,Business Development ,Biologically Inspired Engineering ,Harvard University ,Technnology Development ,Wyss Core Faculty ,Peng Yin ,Disease Control ,Molecular Robotics Initiative ,Systems Biology ,Nuprobe Global ,Digital Biology ,Postdoctoral Fellow ,Tsz Wing ,Acting Head ,Proximity Extension Amplification Reaction ,Validation Project ,Institute Project ,Oliver Tassinari ,Wyss Founding Director Donald Ingber ,Judah Folkman Professor ,Vascular Biology ,Boston Children ,Wyss Professor ,Bioinspired Engineering ,Harvard John ,Research ,Antibodies ,Essay ,Flood ,Children ,Covid 19 ,Iagnostic ,Iagnostics ,Na ,Efficacy ,Hospital ,Immunity ,Immunoassay ,N Vitro ,Laboratory ,Medical School ,Micro ,Anotechnology ,Mh ,Protein ,Cars ,Ars Cov 2 ,Translation ,Vaccine ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.